Evidence map›Paper›PMID 40243365›Full record

ArticlemBio2025

The same but different: impact of animal facility sanitary status on a transgenic mouse model of Alzheimer's disease.

Caroline Ismeurt-Walmsley, Patrizia Giannoni, Florence Servant, Linda-Nora Mekki, Kevin Baranger, Santiago Rivera, Philippe Marin, Benjamin Lelouvier, Sylvie Claeysen

Abstract read
In one paragraph

Article in mBio, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Caroline Ismeurt-WalmsleyIGF, Univ. Montpellier, CNRS, INSERM, Montpellier, Occitanie, France.
Patrizia GiannoniIGF, Univ. Montpellier, CNRS, INSERM, Montpellier, Occitanie, France.
Florence ServantVAIOMER, Labège, France.
Linda-Nora MekkiIGF, Univ. Montpellier, CNRS, INSERM, Montpellier, Occitanie, France.
Kevin BarangerAix-Marseille Univ, CNRS, INP, Inst Neurophysiopathol, Marseille, Provence-Alpes-Côte d'Azur, France.
Santiago RiveraAix-Marseille Univ, CNRS, INP, Inst Neurophysiopathol, Marseille, Provence-Alpes-Côte d'Azur, France.
Philippe MarinIGF, Univ. Montpellier, CNRS, INSERM, Montpellier, Occitanie, France.
Benjamin LelouvierVAIOMER, Labège, France.
Sylvie ClaeysenIGF, Univ. Montpellier, CNRS, INSERM, Montpellier, Occitanie, France.ORCID 0000-0002-0576-5518

Funding

Agence Nationale de la Recherche ANR-15-CE16-0006 (MAD5)Agence Nationale de la Recherche ANR-22-CE36-0003 (DENTALCOG)Association France Alzheimer Aide IndividuelleEuropean Regional Development Fund Recherche & Société(s) 2018 - MICMALZInstitut National de la Santé et de la Recherche Médicale Inserm Cross-Cutting program on MicrobiotaRégion Occitanie Pyrénées-Méditerranée Recherche & Société(s) 2018 - MICMALZSoroptimist International France - Club de Montpellier Metropole Fin de thèseSynAging CIFRE fellowship
6 · The paper itself

Abstract

The gut-brain axis has emerged as a key player in the regulation of brain function and cognitive health. Gut microbiota dysbiosis has been observed in preclinical models of Alzheimer's disease and patients. Manipulating the composition of the gut microbiota enhances or delays neuropathology and cognitive deficits in mouse models. Accordingly, the health status of the animal facility may strongly influence these outcomes. In the present study, we longitudinally analyzed the fecal microbiota composition and amyloid pathology of 5XFAD mice housed in a specific opportunistic pathogen-free (SOPF) and a conventional facility. The composition of the microbiota of 5XFAD mice after aging in conventional facility showed marked differences compared to WT littermates that were not observed when the mice were bred in SOPF facility. The development of amyloid pathology was also enhanced by conventional housing. We then transplanted fecal microbiota (FMT) from both sources into wild-type (WT) mice and measured memory performance, assessed in the novel object recognition test, in transplanted animals. Mice transplanted with microbiota from conventionally bred 5XFAD mice showed impaired memory performance, whereas FMT from mice housed in SOPF facility did not induce memory deficits in transplanted mice. Finally, 18 weeks of housing SOPF-born animals in a conventional facility resulted in the reappearance of specific microbiota compositions in 5XFAD vs WT mice. In conclusion, these results show a strong impact of housing conditions on microbiota-associated phenotypes and question the relevance of breeding preclinical models in specific pathogen-free (SPF) facilities. IMPORTANCE: Housing conditions affect the composition of the gut microbiota. Gut microbiota of 6-month-old conventionally bred Alzheimer's mice is dysbiotic. Gut dysbiosis is absent in Alzheimer's mice housed in highly sanitized facilities. Transfer of fecal microbiota from conventionally bred mice affects cognition. Microbiota of mice housed in highly sanitized facilities has no effect on cognition.

Indexed as

Alzheimer DiseaseGastrointestinal MicrobiomeHousing, AnimalAnimalsDisease Models, AnimalDysbiosisFecal Microbiota TransplantationFecesFemaleMaleMiceMice, TransgenicSpecific Pathogen-Free OrganismsAlzheimer’s diseaseamyloid pathologyanimal facility sanitary statuscognitiongut microbiota

Identifiers

PMID40243365
PMCPMC12077201

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.